Patient Guide: A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 109 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05257083
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: PHASE3

Find a Study Location Near You

This study is available at 109 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Little Rock, Arkansas
  • Duarte, California
  • San Diego, California
  • • And 106 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily